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A B S T R A C T   
Background: Spinal intradural tumors can be classified as intradural extramedullary or intramedullary tumors. 
Spinal meningiomas are among the most frequent intradural, extramedullary tumors (IDEMs), representing 12 % 
of all meningiomas and 25–45 % of all intradural spinal tumors. 
Objective: To evaluate postoperative outcome, defined by mortality, tumor recurrence and modified Rankin Scale 
in patients with spinal meningiomas. Furthermore, to identify factors related to these outcome measures and 
define possible prognosticators. 
Methods: A large single center retrospective analysis of 166 consecutive spinal meningioma patients during a 29- 
year period (1989–2018). 
Results: Female to male ratio was 5.15 to 1. Of all 166 resected tumors, 159 were WHO grade I and seven were 
WHO grade II. Histopathologically, the psammomatous type was most common (42.8 %). The thoracic region 
was the most frequent location (71.1 %), followed by cervical and lumbar locations. A complete resection 
(Simpson I-III) was achieved in 88.7 %. In 12 cases (7.2 %) recurrences of a spinal meningioma occurred after an 
interval of 0.70–13.78 years. Postoperative complications consisted of CSF leakage and wound healing problems. 
Three patients died of direct postoperative complications (1.8 %), nine patients died in follow-up due to unre-
lated causes. Post-operative complications were related to the overall outcome (p = 0.029). Clinical outcome 
showed improvement in 117 patients out of 148 (79.1 %) according to modified Rankin Scale; 24 patients 
remained stable and 7 patients deteriorated. Patients with pre-existing bladder/bowel problems and incomplete 
resections had higher chance of recurrences. Younger patients also had a higher recurrence rate. Follow-up 
ranged from 0 to 23 years, median of 0.77 years, most were discontinued after 2 years. 
Conclusions: The primary treatment of spinal meningiomas remains surgery. Complete resection of spinal me-
ningiomas is achieved in most of the cases, however preserving and improving neurological status has priority 
over complete tumor resection. Morbidity and mortality is relatively low. Longer follow-up periods are recom-
mended, since recurrences can occur after 10–15 years.   
1. Introduction 
Spinal tumors are classified as either extradural or intradural in 
relation to the spinal meninges. Intradural tumors can be further sub-
categorized into extramedullary (IDEM) or intramedullary spinal cord 
tumors (IMSCT). Meningiomas are among the most frequent IDEMs, 
representing about 12 % of all meningiomas [30] and 25 %–45 % of all 
intradural spinal tumors [13,46,6]. Meningiomas are often benign, 
slow-growing tumors with a peak age incidence between 40 and 70 
years and a male:female ratio of 1:4 [38]. 
Their distribution along the spinal axis varies whereby the majority 
(67–84 %) of spinal meningiomas are located within the thoracic region 
[2,11,45]. The incidence of spinal meningiomas in the cervical and 
lumbar region is 14–27 % and 2–14 %, respectively [11]. 
Abbreviations: ASA, American Society of Anesthesiologists; CSF, cerebral spinal fluid; EMG, electromyography; IDEM, intradural, extramedullary tumors; IMSCT, 
intramedullary spinal cord tumors; IONM, intraoperative neuromonitoring; IQR, interquartile range; KPS, Karnofsky Performance Score; MRI, Magnetic resonance 
imaging; mRS, modified Rankin Scale; SD, standard deviation; WHO, World Health Organization. 
* Correspondence author at: Department of Neurosurgery, Erasmus MC, Brain Tumor Center, and Erasmus MC Sophia Children’s Hospital, Dr. Molewaterplein 40, 
NA-2112 PO Box 2040, 3000 CA Rotterdam, the Netherlands. 
E-mail address: r.dammers@erasmusmc.nl (R. Dammers).  
Contents lists available at ScienceDirect 
Clinical Neurology and Neurosurgery 
journal homepage: www.elsevier.com/locate/clineuro 
https://doi.org/10.1016/j.clineuro.2020.106238 
Received 1 June 2020; Received in revised form 31 August 2020; Accepted 12 September 2020   
Clinical Neurology and Neurosurgery 198 (2020) 106238
2
The primary treatment option is surgical resection with the goal to 
achieve complete tumor removal and spinal cord decompression, 
avoiding further neurological deterioration. [32] Outcomes are mostly 
favourable, however not many studies have been published with respect 
to post-operative outcome. Because of further developing minimally 
invasive techniques there is a need for larger cohorts of patients that 
were treated via microsurgical open techniques for future comparison. 
During a 29-year period from 1989 to 2018, 166 patients with spinal 
meningiomas were operated at our institution via an open microsurgical 
approach. In this study, we retrospectively analyzed this cohort of pa-
tients over a long time period. We evaluated mortality, tumor recur-
rence, and neurologic function and searched for possible factors related 
to outcome and recurrence. 
2. Patients and methods 
A consecutive cohort of 166 patients who had undergone open 
microsurgical treatment for spinal meningioma at the Erasmus Medical 
Center from January 1989 until December 2018 was retrospectively 
reviewed. These patient data were extracted from our institutional 
meningioma database. 
Demographics, including patient age, sex, previous medical history, 
ASA classification, presenting symptoms, postoperative complications, 
and length of hospital stay were extracted from the database. Further-
more, the tumor site as well as dural attachment was noted. Perioper-
ative characteristics, such as perioperative complications and Simpson 
grade of resection were scored from the operative report. Surgery was 
performed through microsurgical techniques using an operating mi-
croscope. X-ray localization was used in all patients and when needed 
intraoperative ultrasound imaging was used for localization. Intra-
operative neuromonitoring (IONM) was available since 2009, the use of 
which was extracted from the operative report. 
The 4th edition WHO classification of tumors of the central nervous 
system was used to provide histological characterization [22]. Before 
the WHO classification was introduced, meningiomas were classified 
according to Jääskeläinen [16]. For the purpose of the present study, 
Jääskeläinen type 1 and 2 meningiomas were considered benign me-
ningiomas according to the WHO classification. Recurrence was defined 
as reoperation for tumor recurrence and clinical outcome was evaluated 
through pre- and postoperative modified Rankin scores [44], where the 
functional neurological condition of patients was described in their 
medical files and interpreted by the first author. Alternatively, the 
modified Rankin scores were also dichotomized according to Nurick 
criteria where independent ambulation is of importance [29]. Favour-
able outcome was as such classified as mRS 0–3 and unfavourable as 
mRS 4− 5. 
In the earlier years, there was no standard follow-up scheme. Pa-
tients were generally seen in the outpatient clinic some six weeks after 
discharge. Neurological status determined further follow-up and imag-
ing. Since about 2005 a postoperative MRI is mandated at three months 
and again further follow-up depended on this imaging and neurological 
status. From 2010 on a more strict protocol is followed in which MRI is 
performed at 3 and 6 months, 1, 2, 5, and 10 years after surgery, 
depending on the extent of resection and WHO grade. 
3. Statistical analysis 
All data were analyzed with the commercially available statistical 
software package SPSS® Statistics version 22 (IBM Corp.©). Continuous 
variables were univariately compared using a Student’s T-test for 
parametric data and a Mann-Whitney U test for non-parametric data and 
reported as mean values ± standard deviations (SD). Normal distribu-
tion was tested with Kolmogorov-Smirnov test for skewness and kurto-
sis. Dichotomous and nominal variables were compared with Chi-square 
and Fisher’s exact test, where applicable, and presented as absolute 
numbers and percentages. P-values <0.05 were considered statistically 
significant. 
As outcome measures, death, tumor recurrence and postoperative 
modified Rankin scores were used. In order to analyze factors relating to 
the outcome the variables were initially explored univariately as 
described above. Variables for which there was a high probability of 
association with the outcome (p < 0.20) were considered for the final 
multivariate regression model. Backward stepwise logistic regression 
was used for this purpose and odds ratios (OR) and 95-percent confi-
dence intervals (95 %-CI) and p-values are presented. To exclude the 
possible early effects of surgery, regression analysis was done on all 
patients and on patients with a follow-up of more than 0.5 years 
(n = 90). 
Kaplan-Meier survival analysis was used to estimate the risk of 
recurrence over time. 
4. Results 
4.1. Patient and tumor characteristics 
In this retrospective analysis 166 consecutive patients were included 
with a median follow-up of 0.77 years per patient (range; 0–23 years, 
IQR 4.6 years). 
Table 1 summarizes preoperative patient and tumor characteristics. 
Of 166 patients, 139 were female (83.7 %) and 27 were male (16.2 %). 
The pathology report showed benign meningioma in 159 patients (95.8 
%) and 7 atypical meningiomas (4.2 %). Histologically, the psam-
momatous type meningioma was the most frequent (42.8 %), followed 
by transitional (28.9 %) and meningothelial/syncytial (14.5 %) me-
ningioma. The most common location was the thoracic spinal canal 
(71.1 %). The dural attachment of the spinal meningiomas was pre-
dominantly lateral (62.9 %). Information about tumor size was only 
available in 55 cases, with a mean meningioma volume of 2.1 ± 1.2 mL, 
and a minimum and maximum length of around 10 and 50 mm, 
respectively. Presenting symptoms were mostly motor deficits (84 %), 
followed by sensory deficits (63.1 %), pain (27.6 %) and bladder/bowel 
problems (23.3 %). 
4.2. Surgical outcome 
Of 166 patients, data about Simpson grade resection was found in 
159 (95.8 %) patients. In 141 patients (88.7 %) a complete resection was 
achieved (Simpson grade I-III). In 18 patients (11.3 %) a subtotal 
resection was achieved. In the cervical, thoracic and lumbar spine, 2 (7.4 
%), 13 (11.5 %) and 3 (33.3 %, p = 0.067) incomplete resections were 
observed, respectively. IONM was used in 13 of 65 patients (20 %) since 
its institution in 2009. Lesions with a ventral attachment were more 
commonly operated on with IONM, although not significantly 
(p = 0.123). Some perioperative problems that were encountered were 
hemostasis problems and in one patient the wrong level was operated on 
at first and during operation corrected for the right level. 
Fourty-one postoperative complications occurred in 35 patients 
(21.7 %; Table 2). Seven patients had CSF leakage, which required 
temporary external lumbar drainage. Six patients had wound healing 
problems, requiring antibiotics. Other complications in this study group 
were pneumonia, pulmonary embolus, increased level of pain experi-
ence at the surgical site and worsening of neurologic condition, amongst 
others. 
4.3. Clinical outcome 
Of 161 patients, 85 patients had a preoperative favourable modified 
Rankin Score (mRS 0− 3) and 76 patients had an unfavourable mRS 
score (mRS 4–5). Postoperatively, in 162 patients, there was a favour-
able mRS score in 149 patients and unfavourable score in 13 patients of 
which 12 patients died in the follow-up period. When comparing pre-
operative and postoperative mRS scores (not including total deaths) 117 
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patients (79.1 %) showed clinical improvement, 24 patients (16.2 %) 
remained stable and 7 patients showed deterioration in their mRS (4.7 
%); Table 3. Among the 7 deteriorated patients are 3 patients that died of 
complications directly postoperatively, pertaining a surgical mortality 
of 1.8 % (Table 2). One of these three is an 88-year old patient with a 
pre-operative KPS of 50 who developed pulmonary bleeding post-
operatively followed by hematemesis and respiratory insufficiency. 
Another 88-year old patient developed a wound infection, followed by 
sepsis, eventually succumbing to pulmonary embolism. The third pa-
tient, 61 years old, developed hydrocephalus with spinal cord edema, for 
which an external ventricular shunt was placed. This patient eventually 
succumbed due to respiratory insufficiency. 
Nine patients died during follow-up to causes unrelated to the spinal 
meningioma. 
Of the patients that deteriorated after surgery one had a Brown- 
Séquard syndrome, and another showed worsening of the pre-existing 
paresis. Two other patients developed complications likely related to 
co-morbidities; One had a wound healing disorder resulting in a defect 
requiring a split-skin-graft and another also had wound healing prob-
lems and ileus in the presence of metastasized prostate cancer. Thus, at 
final follow-up 117 patients (73.1 %) showed improvement, 24 patients 
(15 %) remained stable, and 19 patients (11.8 %) deteriorated, which 
included 12 deaths (Table 4). 
Table 1 
Patient demographics and perioperative and tumor characteristics.  
Patient demographics n = 166 
Sex (male : female) 27 : 139 = 1 : 5.15 
Age in years (mean ± SD; range) 66.0 ± 13.5; 13.5–88.7 













ASA physical status (%) 
1 (healthy) 
2 (mild systemic disease) 













Preoperative modified Rankin score (mRS; %) 
Favourable (mRS 0–3) 
Unfavourable (mRS 4–5) 
85/161 (52.8) 
76/161 (47.2) 
Tumor characteristics  




















WHO classification (%) 
Benign (WHO I) 
Atypical (WHO II) 
159 (95.8) 
7 (4.2) 
Perioperative characteristics  
Blood loss in mL (mean ± SD; range) Mean 655 ± 560; 
range 150 – 3000 
Intraoperative neuromonitoring (%) 13/65 (20) 
Simpson resection grade (%) 
I (complete) 
II (complete and coagulation of dural attachment) 
III (complete without resection or coagulation dura) 





Perioperative complication (%) 
Postoperative complication (%) 
8/162 (4.9) 
35/161 (21.7) 
Length of hospital stay in days (mean ± SD; range) 12.3 ± 8.2; 2 – 55 
Follow-up  
Modified Rankin score (mRS) at latest follow-up (%) 
Favourable (mRS 0–3) 
Unfavourable (mRS 4–5) 




Recurrent spinal meningioma for which reoperation(%) 12 (7.2) 
Duration until reoperation in years (mean ± SD; range) 3.4 ± 4.7; 0.1–23.1 
ASA American Society of Anesthesiologists. 
mRS modified Rankin Score, mRS 0: no symptoms, mRS 1: no significant 
disability, mRS 2: slight disability, mRS 3: moderate disability, mRS 4: moder-
ately severe disability, mRS 5: severe disability, mRS 6: dead. 
WHO World Health Organization. 
Simpson grade I: macroscopically complete resection with excision of dural 
attachment and abnormal bone, Simpson grade II: macroscopically complete 
resection with coagulation of dural attachment, Simpson grade III: macroscop-
ically complete resection without resection or coagulation of its attachment, 
Simpson grade IV: subtotal resection, Simpson grade V: simple decompression of 
tumor. 
Table 2 






Postoperative wound infection 
Resulting in sepsis 
6 
1 








Pulmonary embolus 2 
Hyperglycemia due to corticosteroid use 3 
Difficult to treat (wound) pain 3 
Urinary tract infection 3 





Syrinx development 1 
Myelum edema with hydrocephalus and secundary meningitis 1 
Ileus 2 
Cardiac decompensation 2 
Epileptic seizure 1 
Hypertension 1 
Hypotension 1 
Postoperative complications occurring in 35 patients (21.7 %) after surgery for 
spinal meningioma. 
CSF: cerebrospinal fluid. ELD: external lumbar drainage. EVD: external ven-
tricular drainage. 
Table 3 
















mRS 0        
mRS 1 0 2 3 0 0 0 0 
mRS 2 1 6 7 7 1 0 0 
mRS 3 5 13 20 15 3 1 1 
mRS 4 0 4 15 49 5 0 2 
mRS 5 0 0 0 1 0 0 0 
mRS 6        
Crosstable with the preoperative mRS score and the postoperative mRS scores. 
mRS 0: no symptoms, mRS 1: no significant disability, mRS 2: slight disability, 
mRS 3: moderate disability, mRS 4: moderately severe disability, mRS 5: severe 
disability, mRS 6: dead. 
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4.4. Favourable vs. unfavourable factors 
In univariate analysis, presenting symptoms had no relation to 
outcome overall (motor deficits, p = 0.312; sensory deficits, p = 0.642; 
pain, p = 0.281; bladder/bowel deficits, p = 0.776). A non-significant 
more favourable outcome was observed in younger patients 
(p = 0.087) and patients with postoperative complications had a higher 
chance on an unfavourable outcome (p = 0.054). Although non- 
significant, a higher preoperative KPS related to a favourable outcome 
(p = 0.093). Meningioma volume was not related to outcome 
(p = 0.255). In multivariate analysis, only postoperative complications, 
a history of cardiovascular disease, and surgery in the years since the 
introduction of IONM (2009) were correlated to outcome (Table 5). 
When only patients with a follow-up longer than 0.5 years were 
included, only male sex and a previous history of malignancy showed a 
relation to an unfavourable outcome at last follow-up, p = 0.011 and 
p = 0.065 respectively. In multivariate analysis, only male sex and the 
diagnosis of an atypical meningioma proved related to an unfavourable 
outcome at last follow-up. Also, surgery since 2009 had a positive effect 
on outcome (Table 5), although non-significant (p = 0.061). 
4.5. Recurrence 
Recurrences occurred in 12 cases (7.2 %), of which those with an 
incomplete resection, i.e. Simpson grade IV, had a significantly higher 
chance of recurrence (OR 8.362, 95 %-CI 1.757–39.794, p = 0.008). Of 
the 12 cases that recurred 2 were Simpson grade I (6.1 % of 33 patients), 
5 grade II (5.2 % of 96 patients) and 5 grade IV resections (27.8 % of 18 
patients). None of the recurrences had dorsal dural attachments. Mean 
patient age at time of surgery was 66 ± 13.5 years, and a younger age 
related to meningioma recurrence. (OR 0.940, 95 %-CI 0.900− 0.982, 
p = 0.006). Mean duration to reoperation was 5.2 ± 4.4 years in the 
present study. Also, patients presenting with bladder/bowel problems 
had a significantly higher chance of recurrence (OR 4.893, 95 %-CI 
1.181–20.274, p = 0.029). Interestingly, an atypical meningioma did 
not show a significantly higher chance of recurrence on univariate 
analysis (p = 0.082) and did not remain in the multivariate analysis. 
Only one of the six patients with an atypical meningioma received 
radiotherapy. Follow-up periods in those patients ranged from 0.02–15 
years. 
With Kaplan-Meier survival analysis an overall recurrence-free sur-
vival at 5, 10, and 15 years of 91.0 %, 75.9 %, and 59.0 % was observed 
(Fig. 1). For complete resection (Simpson I-III), 10 and 15-year recur-
rence free survival was 86.4 and 67.2 %. For incomplete resection this 
was 21.9 % for both 10 and 15-year recurrence free survival. Because of 
the low numbers of WHO II meningiomas, life table analysis according 
to tumor grading was not applicable. 
5. Discussion 
We report the surgical outcomes of a retrospective cohort of 166 
consecutive patients with spinal meningiomas treated through an open 
microsurgical approach at our institution during a 29-year period. In this 
regard, albeit that it is one of the largest study cohorts presented, the 
main limitation of this study is that it has a retrospective nature. 
5.1. Presenting signs and symptoms 
Most patients were referred to our institution for surgical treatment 
Table 4 
















mRS 0        
mRS 1 0 4 0 0 0 0 0 
mRS 2 1 12 6 3 0 0 0 
mRS 3 4 13 21 12 3 1 4 
mRS 4 0 5 16 44 2 0 8 
mRS 5 0 0 0 1 0 0 0 
mRS 6        
Crosstable with the preoperative mRS score and the postoperative mRS scores. 
mRS 0: no symptoms, mRS 1: no significant disability, mRS 2: slight disability, 
mRS 3: moderate disability, mRS 4: moderately severe disability, mRS 5: severe 
disability, mRS 6: dead. 
Table 5 
Logistic regression model.  
Variables with p-values <0.05 were statistically significant. These variables 
were univariately analyzed in order to analyze relation to outcome. Variables 
with high probability of association with outcome (p < 0.20) were included for 
final multivariate logistic regression model. 
B: coefficient for the constant, OR: Odds ratio, CI: Confidence Interval. 
Fig. 1. Kaplan-Meier survival analysis of overall recurrence-free survival. 
SE = standard error of the mean. The + signs illustrate the patients that were 
censored from the analysis because of end of follow-up. 
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because of progressive neurological deficits, mostly motor deficits. In 
literature, however, the first symptoms patients with spinal meningi-
omas present with are often reported to be local and radicular pain [43, 
24]. In a series by Sandalcioglu et al. 39 % of patients were unable to 
walk at first presentation [34]. Klekamp and Samii reported that 59 % of 
117 patients presented with gait ataxia as predominating neurological 
symptom [19]. Twenty percent complained of pain and 16 % of motor 
weakness. Solero et al. described a series of 174 patients, of which 42 % 
presented with pain, 33 % complained of motor deficits, and 25 % 
complained of sensory deficits [38]. In the most recent large cohort 
study, encompassing 173 patients, 32 % and 33 % of patients com-
plained of motor deficits and pain, respectively, as symptom onset [31]. 
5.2. Tumor characteristics 
In the present study almost all spinal meningiomas were benign, 
WHO grade I. Information about tumor size was only available in 55 
cases, with a mean meningioma volume of 2.1 ± 1.2 mL. The majority 
was located in the thoracic spine region, which is concurrent with 
described literature. Reportedly, in women, spinal meningiomas occur 
in 80 % in the thoracic region [38,21,11,35]. In men however, spinal 
meningiomas occur in only 50 % in the thoracic region [43]. This gender 
difference in relation to spinal meningioma location was not observed in 
the present case series. Furthermore, in our study dural attachment 
originated mostly from the lateral side (62.9 %). Ventrally or ven-
trolaterally located meningiomas have been shown to be a negative 
prognostic factor with regards to functional outcome and Simpson grade 
of resection [31,23], although this could not be established in our series. 
Occurrence and frequency of histopathological subtypes in our study 
were concordant with reported literature [24,35,33,31]. 
Because of the retrospective nature of this large cohort we faced a 
great number of missing values regarding the imaging characteristics. 
We realize this to be a major limitation. Tumor size could not be related 
to either outcome or recurrence, what might as well be explained by the 
limited patients of whom this parameter was known (n = 55). In addi-
tion to site, location in reference to the spinal cord and size, other pa-
rameters, such as spinal cord edema, calcification and spinal stenosis, 
might be of importance to predict extent of resection and outcome 
assessment. [14,34,47] 
5.3. Resection and recurrence 
The extent of resection was based on the surgeon’s opinion according 
to the Simpson grading scale, since direct postoperative MRIs have only 
been introduced recently into our treatment protocol. This in itself 
might be a limitation to the study, although recent studies still show its 
relevance and prognostic value. [12,28] In this study, a complete 
resection (Simpson I-III) was achieved in 88.7 % of cases. This is com-
parable to previous reports where a complete resection ranged from 82 
% to 98 % [38,34,19,21,33,4,9,17,27,36,37,31,14,26,45]. In the present 
study there was no correlation found between tumor size and grade of 
resection or recurrence, which can in part be due to the limited number 
of cases where tumor size was available. 
In 12 cases (7.2 %) recurrences were noted, relatively more in the 
Simpson grade IV group (5 out of 12 cases). Previous studies reported 
recurrence rates of 1.3 %–21.4 %. [13,38,19,21,33,17,46,31,25,40,26, 
45] The definition of recurrence that we used was “reoperation for 
recurrence”, which might well have underestimated true recurrence 
rates. This definition was used since many patients in the past were not 
followed for longer times with MR imaging because of stable neuro-
logical functional state and/or no residual on the last MRI. Nakamura 
et al. described in their series a recurrence rate of 9.7 %, all in patients 
who underwent Simpson grade II resection for ventral lesions [27]. 
Mean duration for reoperation in these patients was 12.2 ± 5.2 years, 
compared to 5.2 ± 4.4 years in the present study. This may be due to a 
shorter follow-up period in our study compared to other series. 
In the present study, patients who presented with bladder/bowel 
problems had a significantly higher chance of recurrence than those who 
did not. To our best knowledge this has not yet been described in other 
studies. Although tumors in the lumbar region presented with bladder/ 
bowel problems relatively more often (56 %, p = 0.033) we are not able 
to explain this finding in relation to meningioma site or extent of 
resection. Because of the low patient count, this might as well be an 
accidental finding of no significance. In this light, however, Raco et al. 
have shown a worse functional outcome after surgery in patients with 
sphincter involvement. [31] 
The present study showed more recurrences in younger patients. This 
finding is similar with Nakamura et al., who reported a recurrence rate 
of 35 % in the under-50-age group compared to 10 % in the older range 
[27]. Also, Cohen-Gadol et al. reported higher recurrence rates in the 
younger compared to the older age groups, 22 % and 5% respectively 
[4]. This finding is most likely due to a longer life expectancy in the 
younger age group. 
5.4. Outcome 
Clinical outcome was determined by the pre- and postoperative 
modified Rankin Scale. Several grading scales have been described. 
There is no consensus, however, which grading system is most appli-
cable when measuring clinical outcome in this particular group of pa-
tients since these scales were designed for spinal traumatic injury (ASIA, 
Frankel), degenerative disease (Nurick, JOA, EMS), or intramedullary 
tumors (McCormick). Most applicable seems the scoring system pro-
posed by Klekamp and Samii, introduced for the clinical evaluation of 
patients with spinal processes. [18] Unfortunately, because of the 
retrospective nature of the study we were not able to reproduce reliable 
data to calculate this score. We postulated that since ambulation is a key 
element in functional outcome, we decided to use the Nurick Scale. As 
such, a cut-off for favourable and unfavourable functional outcome ac-
cording to the modified Rankin Scale was conceived (mRS 0− 3 and mRS 
4–5, respectively). Nevertheless, we are aware that this might unjustly 
depict the outcome of spinal pathology in general. 
This study showed post-surgical improvement in 117 (79.1 %) pa-
tients, 24 (16.2 %) remained stable and 7 (4.7 %) patients deteriorated. 
Sandalcioglu et al. reported in their series of 131 patients improvement 
or stable neurological status in 96.2 % [34], which is comparable to our 
series (95.3 %). Klekamp and Samii showed 80 % improvement after 
1-year follow-up [19]. Solero et al. described 84 % improvement at 
long-term follow-up [38]. In a recent report by Hohenberger et al. 80 % 
of patients showed fully recovered sensory deficits, 76 % showed 
improved gait disorders, and 63.1 % had improvement in motor deficits 
[14]. Potential risk factors for permanent neurological deterioration 
have been described such as tumor calcification, anterior dural adher-
ence, infiltrative meningioma, tumor adherence to spinal cord, worse 
functional grade at onset, prolonged presentation before diagnosis and 
old age [3,47,31,23]. 
One way to prevent worsening of neurological outcome is by 
implementing intraoperative neuromonitoring (IONM), which has been 
available at our institution since 2009. For the surgery of spinal me-
ningioma it has been used on indication, resulting in only 13 patients 
thus far, i.e. in 20 % of all patients operated upon since 2009. These 
numbers are too small to justify statistical analysis or make strong 
conclusions on outcomes. The use of IONM in intramedullary spinal cord 
tumor resection in detecting neurologic injury during resection has been 
reported extensively in literature, however scarcely in IDEM. Korn et al. 
described a sensitivity of 0.82, a specificity of 0.95, with a positive 
predictive value of 0.82, and a negative predictive value of 0.95 with a 
multimodality approach [20]. They used transcranial motor evoked 
potential, somatosensory evoked potential and EMG monitoring in a 
retrospective study, which consisted of 100 patients who underwent 
intradural extramedullary spinal cord tumor resection. Of these, 22 
patients had meningiomas [20]. Ghadirpour et al. reported in their 
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series IONM changes in 5 out of 68 patients with IDEMs (7.3 %) [10]. In 
63 patients (92.7 %) IONM invariably predicted a good neurological 
outcome [10]. In other series, using IONM during surgery of IDEMs 
proved valuable in 5.7–17.7 % [8,15,39,14]. 
Other reported methods to improve surgical outcome are the use of 
the operating microscope and intraoperative ultrasonography, but these 
are not able to monitor neurological function during surgery. Further-
more, precise radiological classification might aid in selecting the most 
adequate and safe surgical corridor for spinal meningioma resection. [1] 
More recently, minimally invasive techniques have been developed 
for the microsurgical resection of intradural spinal tumors. [42,5,7] A 
paraspinal unilateral hemilaminectomy approach centered over the 
lesion has been shown to offer a safe surgical corridor for resection while 
preserving paraspinal muscles, facet complexes, and posterior tendon 
bands [41,48]. This might reduce surgical morbidity and mortality, 
postoperative discomfort, and spinal instability, with equal surgical re-
sults regarding extent of resection and neurological function. Never-
theless, larger randomized clinical trials comparing both open surgery to 
minimally invasive surgery need to be established. 
5.5. Follow-up 
In the present study the follow-up period ranged from 0 to 23 years. 
However, most follow-ups were discontinued after 1–2 years when pa-
tients had improved neurologically and had no signs of residual tumor 
on follow-up MRI scans. Those patients who had recurrences were 
obviously followed for a longer period. Mirimanoff et al. reported 
recurrence-free rates 5, 10, and 15 years after total resection of 93 %, 80 
%, and 68 % respectively, whereas progression-free rates after subtotal 
resection were only 63 %, 45 %, and 9% [25]. Nakamura et al. reported 
that recurrence rates increase progressively with length of follow-up 
after Simpson grade I and II resection; 0%, 3.2 %, and 8% at 5, 10, 
and 15 years respectively [27]. In our series, overall recurrence-free 
survival needing surgery was 91.0 %, 75.9 %, and 59.0 % at 5, 10, 
and 15 years. Recurrence free survival at 15 years was 67.2 % and 21.9 
% for complete resection (Simpson I-III) and incomplete resection, 
respectively. 
There is no defined period described in previous studies on how long 
the follow-up period should be and at which intervals. Recurrences are 
reported even after complete resection, so further study data with longer 
follow-up periods are needed to determine the long-term follow-up 
policy for improving prognosis. For now, at our facility we propose a 
follow-up scheme in which control MR imaging is done within 48 h post- 
operatively, at three and six months, and at yearly intervals up to 3 
years, extending this interval depending on previous imaging, WHO 
grade, neurological status, and life expectancy. 
6. Conclusion 
Spinal meningiomas are benign, slow-growing tumors, for which the 
primary treatment consists of surgical resection in order to remove the 
tumor completely. Peroperative modalities, such as IONM, are valuable 
attributes to prevent neurological deterioration. 
The majority of patients will show improvement of neurological 
function after tumor removal. Mortality may occur in patients of 
extreme high age and with severe co-morbidity. Recurrences occur in 
about 12 % of patients and do not seem to be directly related to WHO 
grade or extent of resection. 
Although recurrences are infrequent they may occur even after 
10–15 years, therefore an individualized follow-up scheme needs to be 
planned based on risk factors for recurrence and prognostic lifespan for 
each individual patient. 
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